155 related articles for article (PubMed ID: 8683992)
21. Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alpha.
Merx K; Müller MC; Kreil S; Lahaye T; Paschka P; Schoch C; Weisser A; Kuhn C; Berger U; Gschaidmeier H; Hehlmann R; Hochhaus A
Leukemia; 2002 Sep; 16(9):1579-83. PubMed ID: 12200666
[TBL] [Abstract][Full Text] [Related]
22. Gender aspects in chronic myeloid leukemia: long-term results from randomized studies.
Berger U; Maywald O; Pfirrmann M; Lahaye T; Hochhaus A; Reiter A; Hasford J; Heimpel H; Hossfeld DK; Kolb HJ; Löffler H; Pralle H; Queisser W; Hehlmann R;
Leukemia; 2005 Jun; 19(6):984-9. PubMed ID: 15830009
[TBL] [Abstract][Full Text] [Related]
23. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
[TBL] [Abstract][Full Text] [Related]
24. [Analysis of cytogenetic response in Ph+ chronic myeloid leukemia patients treated with interferon alpha].
Hong H; Qiu JY; Lai YY; Shi Y; He Q; Dang H; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):269-73. PubMed ID: 12844411
[TBL] [Abstract][Full Text] [Related]
25. Intensive treatment in order to minimize the Ph-positive clone in CML. Danish-Swedish CML Group.
Simonsson B; Oberg G; Björeman M; Björkholm M; Carneskog J; Gahrton G; Hast R; Karl H; Lanng-Nielsen J; Löfvenberg E; Malm C; Turesson I; Udén AM; Vilén L; Weis-Bjerrum O
Bone Marrow Transplant; 1996 May; 17 Suppl 3():S63-4. PubMed ID: 8769705
[TBL] [Abstract][Full Text] [Related]
26. [Chronic myeloid leukemia].
Hehlmann R
Ther Umsch; 1996 Feb; 53(2):82-7. PubMed ID: 8629268
[TBL] [Abstract][Full Text] [Related]
27. A cytogenetic and fluorescence in situ hybridization evaluation of interferon-alpha in the treatment of chronic myeloid leukemia.
Itoh T; Tamura S; Takemoto Y; Kakishita E
Int J Mol Med; 1999 Dec; 4(6):659-63. PubMed ID: 10567680
[TBL] [Abstract][Full Text] [Related]
28. Serial cytogenetic studies in allografted patients with chronic myeloid leukemia.
Bilhou-Nabera C; Bernard P; Marit G; Viard F; Gharbi MJ; Wen Z; Lacombe F; Broustet A; Reiffers J
Bone Marrow Transplant; 1992 Apr; 9(4):263-8. PubMed ID: 1600414
[TBL] [Abstract][Full Text] [Related]
29. An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology.
Silver RT; Woolf SH; Hehlmann R; Appelbaum FR; Anderson J; Bennett C; Goldman JM; Guilhot F; Kantarjian HM; Lichtin AE; Talpaz M; Tura S
Blood; 1999 Sep; 94(5):1517-36. PubMed ID: 10477676
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha: a Cancer and Leukemia Group B study.
Farag SS; Ruppert AS; Mrózek K; Carroll AJ; Pettenati MJ; Le Beau MM; Peterson BL; Powell BL; Ozer H; Silver RT; Larson RA; Bloomfield CD;
Int J Oncol; 2004 Jul; 25(1):143-51. PubMed ID: 15201999
[TBL] [Abstract][Full Text] [Related]
31. Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: follow-up results.
Kantarjian HM; Talpaz M; O'Brien S; Smith TL; Giles FJ; Faderl S; Thomas DA; Garcia-Manero G; Issa JP; Andreeff M; Kornblau SM; Koller C; Beran M; Keating M; Rios MB; Shan J; Resta D; Capdeville R; Hayes K; Albitar M; Freireich EJ; Cortes JE
Clin Cancer Res; 2002 Jul; 8(7):2177-87. PubMed ID: 12114418
[TBL] [Abstract][Full Text] [Related]
32. [Cytogenetic analysis and bcr/abl mRNA detection in chronic myeloid leukemia].
Yao B; Guo M; Pian H
Zhonghua Xue Ye Xue Za Zhi; 1999 Mar; 20(3):137-9. PubMed ID: 11601240
[TBL] [Abstract][Full Text] [Related]
33. Interferon alfa versus chemotherapy for chronic myeloid leukemia: a meta-analysis of seven randomized trials: Chronic Myeloid Leukemia Trialists' Collaborative Group.
J Natl Cancer Inst; 1997 Nov; 89(21):1616-20. PubMed ID: 9362160
[TBL] [Abstract][Full Text] [Related]
34. [Initial treatment of chronic myelogenous leukemia--interferon or bone marrow transplantation].
Urabe A
Gan To Kagaku Ryoho; 1999 Sep; 26(10):1381-6. PubMed ID: 10500523
[TBL] [Abstract][Full Text] [Related]
35. Results of triple therapy with interferon-alpha, cytarabine, and homoharringtonine, and the impact of adding imatinib to the treatment sequence in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in early chronic phase.
O'Brien S; Giles F; Talpaz M; Cortes J; Rios MB; Shan J; Thomas D; Andreeff M; Kornblau S; Faderl S; Garcia-Manero G; White K; Mallard S; Freireich E; Kantarjian HM
Cancer; 2003 Sep; 98(5):888-93. PubMed ID: 12942553
[TBL] [Abstract][Full Text] [Related]
36. Marrow fibrosis, indicator of therapy failure in chronic myeloid leukemia - prospective long-term results from a randomized-controlled trial.
Buesche G; Hehlmann R; Hecker H; Heimpel H; Heinze B; Schmeil A; Pfirrmann M; Gomez G; Tobler A; Herrmann H; Kappler M; Hasford J; Buhr T; Kreipe HH; Georgii A
Leukemia; 2003 Dec; 17(12):2444-53. PubMed ID: 14562117
[TBL] [Abstract][Full Text] [Related]
37. Approaches to the treatment of chronic myeloid leukemia.
Savage DG; Goldman JM
Int J Hematol; 1994 Jul; 60(1):1-21. PubMed ID: 7919235
[TBL] [Abstract][Full Text] [Related]
38. Chronic myelogenous leukemia: a review.
Cortes JE; Talpaz M; Kantarjian H
Am J Med; 1996 May; 100(5):555-70. PubMed ID: 8644769
[TBL] [Abstract][Full Text] [Related]
39. A randomized study of intermediate as compared with high doses of interferon-alpha for chronic myeloid leukemia: no differences in cytogenetic responses.
Peñarrubia MJ; Odriozola J; González C; Massagué I; Miguel A; González San Miguel JD; Pérez Encinas M; Lavilla E; Giraldo MP; Casado LF; Ferrer S; Steegmann JL;
Ann Hematol; 2003 Dec; 82(12):750-8. PubMed ID: 14517691
[TBL] [Abstract][Full Text] [Related]
40. Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.
Johansson B; Fioretos T; Mitelman F
Acta Haematol; 2002; 107(2):76-94. PubMed ID: 11919388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
